Savarino V - Search Results

1

A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD).

Savarino E, Zentilin P, Marabotto E, Bodini G, Della Coletta M, Frazzoni M, de Bortoli N, Martinucci I, Tolone S, Pellegatta G, Savarino V. Savarino E, et al. Among authors: savarino v. Expert Opin Pharmacother. 2017 Sep;18(13):1333-1343. doi: 10.1080/14656566.2017.1361407. Epub 2017 Aug 7. Expert Opin Pharmacother. 2017. PMID: 28754071 Review.

2

Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease?

Savarino V, Mela GS, Zentilin P, Celle G. Savarino V, et al. Gastroenterology. 1990 Nov;99(5):1542-3. doi: 10.1016/0016-5085(90)91211-n. Gastroenterology. 1990. PMID: 2210269 No abstract available.

3

Ulcer heterogeneity: further arguments for a range of antisecretory treatment.

Savarino V, Zentilin P, Celle G, Mela GS. Savarino V, et al. Dig Dis Sci. 1990 Jul;35(7):921-3. doi: 10.1007/BF01536813. Dig Dis Sci. 1990. PMID: 2364852 No abstract available.

4

Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases.

Mela GS, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P. Mela GS, et al. Among authors: savarino v. Scand J Gastroenterol. 1989 Aug;24(6):683-7. doi: 10.3109/00365528909093109. Scand J Gastroenterol. 1989. PMID: 2573144

5

Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.

Celle G, Savarino V, Mela GS, Scalabrini P, Sumberaz A, Fera G, Zentilin P. Celle G, et al. Among authors: savarino v. Scand J Gastroenterol. 1988 May;23(4):385-90. doi: 10.3109/00365528809093884. Scand J Gastroenterol. 1988. PMID: 2898167 Clinical Trial.

6

Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus?

Savarino V, Mela GS, Zentilin P, Celle G, Vigneri S. Savarino V, et al. Am J Gastroenterol. 1995 May;90(5):845-6. Am J Gastroenterol. 1995. PMID: 7733108 No abstract available.

7

Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients.

Savarino V, Mela GS, Zentilin P, Malesci A, Vigneri S, Sossai P, Di Mario F, Cutela P, Mele MR, Celle G. Savarino V, et al. Scand J Gastroenterol. 1993 Sep;28(9):772-6. doi: 10.3109/00365529309104007. Scand J Gastroenterol. 1993. PMID: 8235432

8

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

Savarino V, Mela GS, Zentilin P, Mele MR, Vigneri S, Mansi C, Celle G. Savarino V, et al. Aliment Pharmacol Ther. 1996 Jun;10(3):367-72. doi: 10.1111/j.0953-0673.1996.00367.x. Aliment Pharmacol Ther. 1996. PMID: 8791965 Clinical Trial.

9

Long-term therapy of gastro-oesophageal reflux disease: medical or surgical?

Savarino V. Savarino V. Dig Liver Dis. 2000 Dec;32 Suppl 3:S249-52. doi: 10.1016/s1590-8658(00)80293-5. Dig Liver Dis. 2000. PMID: 11245310 No abstract available.

10

Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.

Frazzoni M, De Micheli E, Grisendi A, Savarino V. Frazzoni M, et al. Among authors: savarino v. Aliment Pharmacol Ther. 2002 Jan;16(1):35-9. doi: 10.1046/j.1365-2036.2002.01138.x. Aliment Pharmacol Ther. 2002. PMID: 11856076 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters